Mammalian Mip/LIN-9 interacts with either the p107, p130/E2F4 repressor complex or B-Myb in a cell cycle-phase-dependent context distinct from the Drosophila dREAM complex

被引:95
|
作者
Pilkinton, M. [1 ]
Sandoval, R. [1 ]
Colamonici, O. R. [1 ]
机构
[1] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA
关键词
cell cycle; LIN-9; pocket proteins; CDK; cyclin; Myb;
D O I
10.1038/sj.onc.1210562
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mammalian Mip/LIN-9 is a cell cycle regulatory protein that is negatively regulated by CDK4/cyclin D. It has been demonstrated that Mip/LIN-9 collaborates with B-Myb during S and G2/M in the induction of cyclins A and B, and CDK1. The ortholog of Mip/LIN-9 in (D) under bar rosophila, Mip130, is part of a large multisubunit protein complex that includes (R) under bar BF, repressor (E) under bar 2Fs (a) under bar nd (M) under bar yb, in what was termed the dREAM complex. A similar complex, although lacking B-Myb, was also described in Caenorhabditis elegans. Here, we demonstrate that unlike Drosophila, Mip/LIN-9 has mutually exclusive and cell cycle-phasespeci. c interactions with the mammalian orthologs of the dREAM complex. In G(0)/early G(1), Mip/LIN-9 forms a complex with E2F4 and p107 or p130, while in late G(1)/S phase, it associates with B-Myb. The separation of Mip/LIN-9 from p107, p130/E2F4 is likely driven by phosphorylation of the pocket proteins by CDK4 since Mip/LIN-9 fails to interact with phosphorylated forms of p107, p130. Importantly, the repressor complex that Mip/LIN-9 forms with p107 takes functional precedence over the transcriptional activation linked to the Mip/LIN-9 and B-Myb interaction since expression of p107 blocks the activation of the cyclin B promoter triggered by B-Myb and Mip/LIN-9.
引用
收藏
页码:7535 / 7543
页数:9
相关论文
共 6 条
  • [1] Mammalian Mip/LIN-9 interacts with either the p107, p130/E2F4 repressor complex or B-Myb in a cell cycle-phase-dependent context distinct from the Drosophila dREAM complex
    M Pilkinton
    R Sandoval
    O R Colamonici
    Oncogene, 2007, 26 : 7535 - 7543
  • [2] Deletion of the p107/p130-binding domain of Mip130/LIN-9 bypasses the requirement for CDK4 activity for the dissociation of Mip130/LIN-9 from p107/p130-E2F4 complex
    Sandoval, Raudel
    Pilkinton, Mark
    Colamonici, Oscar R.
    EXPERIMENTAL CELL RESEARCH, 2009, 315 (17) : 2914 - 2920
  • [3] E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry
    Moberg, K
    Starz, MA
    Lees, JA
    MOLECULAR AND CELLULAR BIOLOGY, 1996, 16 (04) : 1436 - 1449
  • [4] Expression of cell cycle-regulated proteins pRR2/p130, p107, E2F4, p27, and pCNA in salivary gland tumors: prognostic and diagnostic implications
    Russo, G
    Zamparelli, A
    Howard, CM
    Minimo, C
    Bellan, C
    Carillo, G
    Califano, L
    Leoncini, L
    Giordano, A
    Claudio, PP
    CLINICAL CANCER RESEARCH, 2005, 11 (09) : 3265 - 3273
  • [5] Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence
    Litovchick, Larisa
    Sadasivam, Subhashini
    Florens, Laurence
    Zhu, Xiaopeng
    Swanson, Selene K.
    Velmurugan, Soundarapandian
    Chen, Runsheng
    Washburn, Michael P.
    Liu, X. Shirley
    DeCaprio, James A.
    MOLECULAR CELL, 2007, 26 (04) : 539 - 551
  • [6] Cell cycle regulators p105, p107, rb2/p130, E2F4, p21CIP1/WAF1 cyclin A in predicting cervical intraepithelial neoplasia, high-risk human papillomavirus infections and their outcome in women screened in three new independent states of the former Soviet Union
    Santopietro, Rosa
    Shabalova, Irena
    Petrovichev, Nicolay
    Kozachenko, Vladimir
    Zakharova, Tatjana
    Pajanidi, Julia
    Podistov, Jurij
    Chemeris, Galina
    Sozaeva, Larisa
    Lipova, Elena
    Tsidaeva, Irena
    Ivanchenko, Olga
    Pshepurko, Alla
    Zakharenko, Sergej
    Nikitina, Maritta
    Grunberga, Valerija
    Grunberg, Alexandr
    Juschenko, Anna
    Cintorino, Marcella
    Tosi, Piero
    Syrjanen, Kari
    Syrjanen, Stina
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (07) : 1250 - 1256